Food and Drug Administration
Process Analytical Technologies (PAT) Subcommittee of the
Advisory Committee for Pharmaceutical Science
February 25, 2002
Slides
Overview and Objectives, Ajaz S Hussain, PhD, Office of Pharmaceutical Science, FDA ppt htm
Applications and Benefits of PAT, Steve Hammond, Global Manufacturing Services ppt htm
Pharma Manufacturing: Why there is a need to improve. The role of PAT, Dr Doug Dean, Frances Bruttin, PWC Consulting ppt htm
Process Analytical Technology: An Industry Perspective, John G Shabushnig, PhD, Pharmacia Corporation ppt htm
Process Analytical Technologies Subcommittee Product Process Development: An Industry Perspective, David Rudd PhD, GlaxoSmithKline Research and Development ppt htm
Perspective on Process and Analytical Validation, Robert S Chisholm, AstraZeneca ppt htm
Process and Method Validation, Leon Lachman, PhD, Lachman Consultant Services Inc ppt htm
Chemometrics and PAT: An Opinion on Current Status and Recommendations for the Future, Jerry Workman Jr, Kimberly-Clark Corp ppt htm
Perspectives in Chemometrics, Experience Form GlaxoSmithKline ppt htm
Open Public Hearing
Extended Range NIR Wavelength Standard, Gabor J Kemeny PhD, Kemtek Analytical Inc ppt htm
How to Test for Linearity, Howard Mark, Mark Electronics pdf htm doc